Small increase in lung cancer risk after radiotherapy for breast cancer
Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumor.
Diagnosis & Disease Information
Interval tumors found in six percent of colorectal cancer cases
Interval cancers more likely to be earlier stage, proximal, have lower risk of death
Treatment priorities set for early breast tumors
A team of stakeholders has detailed research priorities necessary to address gaps in knowledge about early breast tumors in women.
Antioxidants increase lung tumor growth in mice
Supplementation with antioxidants markedly increases tumor cell proliferation and tumor growth in mice, researchers found.
Radiation therapy provides tumor control in bladder cancer
Standard and reduced high-dose volume RT for muscle-invasive bladder cancer provides comparable tumor control and decreased late toxicity compared with surgery, according to a new study.
Shorter radiotherapy schedules may compensate for between-dose tumor cell growth
Researchers have estimated the daily dose of radiation therapy that is wasted in compensating for cancer cell growth that occurs overnight and during weekends in patients with early breast cancer, which could shorten radiation therapy schedules.
Immune system harnessed to fight pancreatic cancer
Substantial tumor regressions among some patients with advanced pancreatic cancer occurred in a recent clinical trial that paired the standard chemotherapy for pancreatic cancer, gemcitabine, with an agonist CD40 antibody.
Adolescent radiotherapy increases likelihood of later estrogen-negative breast tumors
Increased stem cell self-renewal and subsequent mammary stem cell enrichment are the culprits of breast cancer that develops later among women who were exposed to ionizing radiation as young women, according to a new study.
First randomized trial of targeted cancer medicine in all tumor types
The SHIVA trial is the first randomized trial to look at patient outcomes after treatments were chosen based on individual molecular profiles of each person’s tumor.
Tumors subtyped by shared genetic effects
Cancer tumors almost never share the exact same genetic mutations, which is a fact that has confounded scientific efforts to better categorize cancer types and develop more targeted, effective treatments.
- Loading...
Loading...
Loading... 
Loading...